potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium

C131H136BBrCl4F4K3N28O11P — CID 159208895

IUPACpotassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium
SMILESC.C=O.CC(C)(C)OC(=O)N1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.CC(C)(C)OC(=O)N1CCN(CCn2cc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(-c3cnn(CCN4CCNCC4)c3)c2)c2cccnc2n1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(Br)c2)c2cccnc2n1.O=[P+]([O-])O[O-].[K+].[K][K]
InChIInChI=1S/C33H33ClFN7O2.C29H27ClFN7.C28H25ClFN7.C20H35BN4O4.C19H10BrClFN3.CH2O.CH4.3K.HO4P/c1-33(2,3)44-32(43)41-12-9-40(10-13-41)11-14-42-21-24(20-38-42)22-15-23(19-36-18-22)27-17-30(28-16-25(34)6-7-29(28)35)39-31-26(27)5-4-8-37-31;1-36-7-9-37(10-8-36)11-12-38-19-22(18-34-38)20-13-21(17-32-16-20)25-15-28(26-14-23(30)4-5-27(26)31)35-29-24(25)3-2-6-33-29;29-22-3-4-26(30)25(13-22)27-14-24(23-2-1-5-33-28(23)35-27)20-12-19(15-32-16-20)21-17-34-37(18-21)11-10-36-8-6-31-7-9-36;1-18(2,3)27-17(26)24-11-8-23(9-12-24)10-13-25-15-16(14-22-25)21-28-19(4,5)20(6,7)29-21;20-12-6-11(9-23-10-12)15-8-18(16-7-13(21)3-4-17(16)22)25-19-14(15)2-1-5-24-19;1-2;;;;;1-4-5(2)3/h4-8,15-21H,9-14H2,1-3H3;2-6,13-19H,7-12H2,1H3;1-5,12-18,31H,6-11H2;14-15H,8-13H2,1-7H3;1-10H;1H2;1H4;;;;1H/q;;;;;;;;;+1;/p-1
InChIKeyKQFVIABRKFSZKK-UHFFFAOYSA-M
MW2735.50 g/mol
LogP19.39
Rot. Bonds25

About potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium

potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium (PubChem CID 159208895) has the molecular formula C131H136BBrCl4F4K3N28O11P and a molecular weight of 2735.50 g/mol. Its IUPAC name is potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium.

Molecular Properties

Compound Namepotassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium
PubChem CID159208895
Molecular FormulaC131H136BBrCl4F4K3N28O11P
Molecular Weight2735.50 g/mol
Exact Mass2730.76
IUPAC Namepotassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium
SMILESC.C=O.CC(C)(C)OC(=O)N1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.CC(C)(C)OC(=O)N1CCN(CCn2cc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(-c3cnn(CCN4CCNCC4)c3)c2)c2cccnc2n1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(Br)c2)c2cccnc2n1.O=[P+]([O-])O[O-].[K+].[K][K]
InChIInChI=1S/C33H33ClFN7O2.C29H27ClFN7.C28H25ClFN7.C20H35BN4O4.C19H10BrClFN3.CH2O.CH4.3K.HO4P/c1-33(2,3)44-32(43)41-12-9-40(10-13-41)11-14-42-21-24(20-38-42)22-15-23(19-36-18-22)27-17-30(28-16-25(34)6-7-29(28)35)39-31-26(27)5-4-8-37-31;1-36-7-9-37(10-8-36)11-12-38-19-22(18-34-38)20-13-21(17-32-16-20)25-15-28(26-14-23(30)4-5-27(26)31)35-29-24(25)3-2-6-33-29;29-22-3-4-26(30)25(13-22)27-14-24(23-2-1-5-33-28(23)35-27)20-12-19(15-32-16-20)21-17-34-37(18-21)11-10-36-8-6-31-7-9-36;1-18(2,3)27-17(26)24-11-8-23(9-12-24)10-13-25-15-16(14-22-25)21-28-19(4,5)20(6,7)29-21;20-12-6-11(9-23-10-12)15-8-18(16-7-13(21)3-4-17(16)22)25-19-14(15)2-1-5-24-19;1-2;;;;;1-4-5(2)3/h4-8,15-21H,9-14H2,1-3H3;2-6,13-19H,7-12H2,1H3;1-5,12-18,31H,6-11H2;14-15H,8-13H2,1-7H3;1-10H;1H2;1H4;;;;1H/q;;;;;;;;;+1;/p-1
InChIKeyKQFVIABRKFSZKK-UHFFFAOYSA-M
XLogP19.39
TPSA421.22 Ų
H-Bond Donors1
H-Bond Acceptors37
Rotatable Bonds25
Heavy Atoms184
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002735.50
LogP ≤ 519.39
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium?
The IUPAC name of potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium (CID 159208895) is potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium.
What is the SMILES notation for potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium?
The canonical SMILES for potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium is C.C=O.CC(C)(C)OC(=O)N1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.CC(C)(C)OC(=O)N1CCN(CCn2cc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(CCn2cc(-c3cncc(-c4cc(-c5cc(Cl)ccc5F)nc5ncccc45)c3)cn2)CC1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(-c3cnn(CCN4CCNCC4)c3)c2)c2cccnc2n1.Fc1ccc(Cl)cc1-c1cc(-c2cncc(Br)c2)c2cccnc2n1.O=[P+]([O-])O[O-].[K+].[K][K].
What is the InChIKey of potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium?
The InChIKey is KQFVIABRKFSZKK-UHFFFAOYSA-M. The full InChI is InChI=1S/C33H33ClFN7O2.C29H27ClFN7.C28H25ClFN7.C20H35BN4O4.C19H10BrClFN3.CH2O.CH4.3K.HO4P/c1-33(2,3)44-32(43)41-12-9-40(10-13-41)11-14-42-21-24(20-38-42)22-15-23(19-36-18-22)27-17-30(28-16-25(34)6-7-29(28)35)39-31-26(27)5-4-8-37-31;1-36-7-9-37(10-8-36)11-12-38-19-22(18-34-38)20-13-21(17-32-16-20)25-15-28(26-14-23(30)4-5-27(26)31)35-29-24(25)3-2-6-33-29;29-22-3-4-26(30)25(13-22)27-14-24(23-2-1-5-33-28(23)35-27)20-12-19(15-32-16-20)21-17-34-37(18-21)11-10-36-8-6-31-7-9-36;1-18(2,3)27-17(26)24-11-8-23(9-12-24)10-13-25-15-16(14-22-25)21-28-19(4,5)20(6,7)29-21;20-12-6-11(9-23-10-12)15-8-18(16-7-13(21)3-4-17(16)22)25-19-14(15)2-1-5-24-19;1-2;;;;;1-4-5(2)3/h4-8,15-21H,9-14H2,1-3H3;2-6,13-19H,7-12H2,1H3;1-5,12-18,31H,6-11H2;14-15H,8-13H2,1-7H3;1-10H;1H2;1H4;;;;1H/q;;;;;;;;;+1;/p-1.
What are the key properties of potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium?
potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium has a molecular weight of 2735.50 g/mol, XLogP of 19.39, 25 rotatable bonds, 1 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;4-(5-bromo-3-pyridinyl)-2-(5-chloro-2-fluorophenyl)-1,8-naphthyridine;tert-butyl 4-[2-[4-[5-[2-(5-chloro-2-fluorophenyl)-1,8-naphthyridin-4-yl]-3-pyridinyl]pyrazol-1-yl]ethyl]piperazine-1-carboxylate;tert-butyl 4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]piperazine-1-carboxylate;2-(5-chloro-2-fluorophenyl)-4-[5-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;2-(5-chloro-2-fluorophenyl)-4-[5-[1-(2-piperazin-1-ylethyl)pyrazol-4-yl]-3-pyridinyl]-1,8-naphthyridine;formaldehyde;methane;oxido-oxidooxy-oxophosphanium;potassiopotassium is sourced from PubChem (CID 159208895), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).